Skip to main content

MARSHALL WACE, LLP

Position in IRWD — Ironwood Pharmaceuticals Inc

CIK 1318757 LONDON, X0

Position in IRWD

as of Mar 31, 2026 · filed May 15, 2026
Position Value
$15,882,974
+$974,088 QoQ
Shares Held
4,525,064
+2.3% QoQ
Ownership
2.75%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Mar 2020
13 quarters on record
Voting authority Sole 0.ToString("F0")% Shared 100.ToString("F0")% None 0.ToString("F0")%

Common Shares in IRWD Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Mar 31, 2026

MARSHALL WACE, LLP holds $558,161,566 across 33 Drug Manufacturers - Specialty & Generic names. IRWD ranks #12 (2.8% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in IRWD

Export CSV
13 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $15,882,974 4,525,064
2025-12-31 $14,908,886 4,424,002
2025-09-30 $4,118,821 3,144,139
2025-06-30 $2,875,361 3,993,557
2025-03-31 $819,555 557,521
2024-06-30 $1,416,261 217,218
2024-03-31 $4,986,475 572,500
2023-12-31 $3,292,660 287,820
2023-09-30 $1,422,784 147,745
2021-03-31 $149,253 13,350
2020-09-30 $1,565,015 174,084
2020-06-30 $1,162,486 112,644
2020-03-31 $1,698,106 168,296